Henry Meds Alternative With a Real Weekly-Shot Tracker
MeAgain is the best Henry Meds alternative for GLP-1 users because it pairs a stronger daily app, lower self-pay pricing, and no upfront prepayment. Henry Meds lists compounded semaglutide injection at $297/month, or about $197/month only if you pay $2,364 upfront for 12 months. MeAgain — the GLP-1 tracking app used by 286,000 users with a 4.8-star App Store rating across over 15,000 ratings — pairs $123/month semaglutide or $199/month tirzepatide with a $9.99/month app subscription. Henry Meds also lists oral tirzepatide tablets instead of compounded injectable tirzepatide. MeAgain adds the daily tracking tools Henry Meds does not show publicly: a shot day checklist, medication graph, injection site rotation tracking, side effect logging for 20 symptoms, food logging, and the Capybara home screen widget. Medication ships in 5–7 days from US-based 503A and 503B pharmacies after clinician review.
Key takeaways
- 1.MeAgain saves about $164/month all-in on semaglutide compared with Henry Meds' standard monthly rate: $297 at Henry versus $132.99 for MeAgain semaglutide plus the monthly app subscription. Even Henry's best 12-month prepay rate still costs more and requires $2,364 upfront.
- 2.MeAgain offers compounded injectable tirzepatide at $199/month flat. Henry Meds currently only offers oral tirzepatide tablets (3-month supply at $1,047 or $891 prepaid) — no injectable version on their official pricing page.
- 3.With 286,000 users and a 4.8-star App Store rating across over 15,000 ratings, MeAgain is a GLP-1 tracking app built around the full week: shots, symptoms, food, hydration, weight, and progress in one place instead of scattered across apps and notes.
- 4.MeAgain subscribers have made the Capybara home screen widget part of their daily routine, which tracks protein, water, fiber, and steps and shifts the Capy's mood when any of them is low. MeAgain turns daily targets into a virtual pet companion you can see from the home screen instead of only after a hard week.
- 5.MeAgain medication ships in 5–7 days from US-based 503A and 503B pharmacies after a licensed clinician reviews the in-app intake. Henry Meds also uses compounded telehealth, but MeAgain pairs that access with a stronger daily app and simpler month-to-month pricing.
MeAgain vs Henry Meds: Lower Self-Pay Cost + Daily GLP-1 App
Henry Meds sells compounded semaglutide through an asynchronous telehealth flow with clinician review, medication, and supplies bundled into one price: $297/month on monthly billing, or about $197/month only if you prepay 12 months upfront. MeAgain keeps semaglutide lower, offers flat tirzepatide pricing, and adds a separate app subscription plus a daily GLP-1 app used by 286,000 people. Both companies use compounded medication from US-based pharmacies. The clearest differences are the lower month-to-month math, no big upfront prepay, and the day-to-day tracking tools MeAgain adds after the prescription starts.
| Feature | MeAgain | Henry Meds |
|---|---|---|
| GLP-1 daily tracking app (286K users) | ||
| Lower semaglutide all-in cost | ||
| Compounded injectable tirzepatide | ||
| Shot day checklist with prep steps | ||
| Estimated medication levels chart | ||
| Injection site rotation tracking | ||
| Side effect tracking (severity slider, 20 symptoms) | ||
| Capybara home screen widget | ||
| Compounded GLP-1 medication access | ||
| Sublingual semaglutide (oral drops) | ||
| Daily liraglutide injection |
What Makes MeAgain a Better Henry Meds Alternative?
01Lower Semaglutide Cost Without a 12-Month Prepay
Henry Meds lists compounded semaglutide injection at $297/month on standard monthly billing. Their lower rate comes from paying $2,364 upfront for 12 months, which works out to about $197/month. MeAgain keeps semaglutide at $123/month and adds a separate app subscription, so the all-in monthly math is $132.99 with no long-term commitment. That makes MeAgain about $164/month cheaper than Henry on monthly billing and about $64/month cheaper even against Henry's best prepay rate. The price stays flat across doses, and billing stays month to month. For people who want to try treatment without locking up a full year of cash before they know the routine fits, that simpler structure matters as much as the sticker price.
02Injectable Tirzepatide at a Flat Monthly Price
Henry Meds' current pricing page lists oral tirzepatide tablets at $1,047 for a 3-month supply, or $891 prepaid, but it does not list compounded injectable tirzepatide. MeAgain offers compounded injectable tirzepatide at $199/month flat across doses after a licensed clinician reviews the in-app intake. That matters because most of the weight-loss data people cite for tirzepatide comes from the weekly injectable form. In SURMOUNT-1, published in the New England Journal of Medicine, 2,539 adults taking injectable tirzepatide lost an average of 20.9% of body weight at 72 weeks. Henry Meds does offer oral tirzepatide if a needle-free format matters most. MeAgain is the clearer fit if you want the injectable option plus a daily app built around weekly shots.
03A Daily GLP-1 App for the Week Between Shipments
Henry Meds is an asynchronous telehealth service: online intake, clinician review, medication delivered every 60 days. MeAgain adds the layer people use after the order is placed, with a GLP-1 app used by 286,000 people. The weekly prep checklist walks through injection day step by step. The weekly chart shows how the week is unfolding. Injection site rotation tracking remembers where you last injected, so the next dose is easier to plan. Side effect logging covers 20 built-in symptoms with a 0–10 severity slider, plus custom entries. Food logging, water, weight, and reminders live in the same place. Henry Meds handles telehealth access. MeAgain keeps the daily routine visible between shipments.
04A Home Screen Widget That Keeps the Day Visible
The Capybara home screen widget turns protein, water, fiber, and steps into a live picture of how the day is going, with mood shifts tied to your protein, water, fiber, and activity. Many MeAgain subscribers have made it part of their daily routine because the reminder sits on the home screen instead of inside a once-a-week check-in. Capy, the in-app AI companion, can help log meals, talk through side effects, and keep routine questions in one conversation. Journey Cards turn progress photos into milestone cards tied to dates or weight changes. Henry Meds is built around prescription access. MeAgain adds the visual reminders and habit-building tools that stay useful after the medication ships.
Henry Meds vs MeAgain: Self-Pay Math and Daily Support
Henry Meds and MeAgain both offer compounded GLP-1 access, but they solve different parts of the experience. Henry Meds focuses on the telehealth side: asynchronous clinician review, compounded medication, and shipments every 60 days. Their current official pricing page lists compounded semaglutide injection at $297/month, or about $197/month if you prepay $2,364 for 12 months. MeAgain combines lower flat medication pricing with a separate app subscription and month-to-month billing. That makes the one-month semaglutide math meaningfully lower with MeAgain while also adding the app people open between injections. The big GLP-1 trials show why that daily support matters. In STEP-1, 1,961 adults taking semaglutide lost 14.9% of body weight at 68 weeks. In SURMOUNT-1, 2,539 adults taking tirzepatide lost 20.9% at 72 weeks. Long treatment works best when the routine stays consistent week after week.
| Factor | Henry Meds | MeAgain |
|---|---|---|
| Medication options | Compounded semaglutide, sublingual semaglutide, oral tirzepatide, liraglutide | Compounded semaglutide and injectable tirzepatide |
| 1-month semaglutide all-in | $297 | $132.99 |
| Best semaglutide long-term rate | $2,364 upfront (~$197/mo) | $132.99/mo, billed monthly |
| Injectable tirzepatide | Not currently listed | $199/mo flat |
| Oral tirzepatide | $1,047 for 3 months ($891 prepaid) | Not offered |
| App subscription | None | $9.99/mo |
| Pharmacy | US compounding (503B-registered) | US-based 503A and 503B |
| Shipping | Every 60 days, 8-10 business days | 5–7 days after approval |
| Daily GLP-1 tracking app | No daily tracking app shown publicly | Purpose-built, 286K users |
| Shot day checklist | No | Yes — step-by-step prep workflow |
| Estimated medication levels chart | No | Yes — weekly chart |
| Capybara widget | No | Yes — home screen companion |
| Side effect tracking | No | Yes — severity slider, custom symptoms |
| App Store rating for daily app | n/a | 4.8 stars, over 15,000 ratings |
We make money from our $9.99/month app subscription. That's it. Henry Meds builds more of the revenue into medication pricing, so their lowest semaglutide rate shows up only when you prepay $2,364 for a full year. MeAgain keeps medication pricing flat, then charges separately for the app people open between shipments. That app covers the weekly prep checklist, medication graph, injection site rotation tracking, side effect logging, food logging, and the Capybara home screen widget. Henry Meds does offer sublingual semaglutide, oral tirzepatide tablets, and liraglutide, which can matter if you want those formats. If you want standard compounded semaglutide with simpler month-to-month pricing and stronger daily support, MeAgain is the cleaner fit. Whichever medication a licensed clinician recommends, the tracker works with it, and the in-app intake is available inside MeAgain for eligible subscribers.
This content is for informational purposes only and does not constitute medical advice. Pricing information is based on publicly available data as of April 2026 and may change. Always consult your doctor about GLP-1 medications.
Sources
- Wilding JPH et al. — Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1, NEJM 2021, n=1,961)
- Jastreboff AM et al. — Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539)
- FDA — Compounded Drug Products: Section 503A and 503B Pharmacies
- FDA — Medications Containing Semaglutide for Type 2 Diabetes and Weight Loss
- FDA — Tirzepatide Drug Information (FDA Drugs@FDA database)
- Henry Meds Programs and Pricing
What Are Real Users Saying About This Henry Meds Alternative?
Why People Choose MeAgain Over Henry Meds
People comparing Henry Meds to MeAgain are usually deciding whether they want telehealth access alone or telehealth plus daily support. As one App Store reviewer (ThickGirlNani, April 2, 2026) wrote: “So glad I found this app. It helps me stay accountable and track all of progress. I highly recommend it if you are on a GLP1 journey.” That is the gap this comparison keeps coming back to: Henry Meds handles the prescription, while MeAgain keeps food, symptoms, injections, and progress in one app once treatment starts.
Henry Meds offers compounded semaglutide through an asynchronous telehealth flow at $297/month on monthly billing or about $197/month with a 12-month prepay. MeAgain keeps semaglutide lower, adds a separate app subscription, and gives you the daily tools Henry does not show publicly: prep guidance, food logging, side effect tracking, the home screen widget, and the AI companion.
What Our Users Say
“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“The Me Again app has been super helpful for managing my Wegovy journey. I love the reminder features and how easy it is to change the units — those tools make staying on track so much easier.”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I honestly really like this app! It has been very useful in helping me track my protein and water while on tirzepatide. I love the cutie capybara I have to take care of every day, it's motivating!”
Henry Meds Alternative - FAQs
Choose MeAgain if you want lower semaglutide costs and a stronger daily GLP-1 app in the same product. Henry Meds is a real telehealth option with compounded semaglutide, oral tirzepatide tablets, sublingual semaglutide, and liraglutide. MeAgain is different: it pairs lower flat medication pricing with a monthly app subscription and tools people use between shipments. Inside the app, users get a shot day checklist, a weekly medication chart, injection site rotation tracking, side effect logging for 20 symptoms, food logging, Capy, and the home screen widget. If you mainly want Henry's alternate formats, Henry may fit better. If you want month-to-month self-pay math plus a daily app built around the weekly GLP-1 routine, MeAgain is the stronger Henry Meds alternative.
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.